Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1983]
News [3213]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Common blood pressure drug may make leukemia more responsive to chemotherapy while protecting heart
Common blood pressure drug may make leukemia more responsive to chemotherapy while protecting heart
FDA grants accelerated approval to epcoritamab-bysp for relapsed or refractory follicular lymphoma
FDA grants accelerated approval to epcoritamab-bysp for relapsed or refractory follicular lymphoma
Reduced infections seen in CLL and NHL patients undergoing immunoglobulin testing and replacement therapy
Reduced infections seen in CLL and NHL patients undergoing immunoglobulin testing and replacement therapy
EHA 2024: Updated linvoseltamab data showcase continued deepening of responses in patients with heavily pre-treated multiple myeloma
EHA 2024: Updated linvoseltamab data showcase continued deepening of responses in patients with heavily pre...
CAR NK cells with CD28 costimulation improved cell persistence and antitumour activity
CAR NK cells with CD28 costimulation improved cell persistence and antitumour activity
Researchers uncover mechanism that fuels growth of aggressive B-cell lymphoma
Researchers uncover mechanism that fuels growth of aggressive B-cell lymphoma
Ultrasensitive liquid biopsy tech spots cancer earlier than standard methods
Ultrasensitive liquid biopsy tech spots cancer earlier than standard methods
FDA approves blinatumomab as consolidation for CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukaemia
FDA approves blinatumomab as consolidation for CD19-positive Philadelphia chromosome-negative B-cell precursor...
Trametinib shows promise for children with relapsed or refractory JMML
Trametinib shows promise for children with relapsed or refractory JMML
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Risk of secondary cancers after CAR-T cell therapy low, according to large study

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation